Key Highlights: Implications: Mankind Pharma’s exclusive agreement with Chongqing Chenan adds two insulin analogues to its India portfolio, strengthening its position in the injectable diabetes segmen...
Key Highlights: Implications: By selling the Roorkee and Noida plants (for around ₹56 crore) but retaining brands, trademarks, its Beauty Entrepreneur network, and all commercial operation...
